Present Status and Perspectives on Future Roles of Japanese Clinical Research Coordinators

Abstract

BackgroundThe new Clinical Trials Act that recently came into effect in Japan emphasizes the reliability of investigator-initiated clinical trials. Although Japanese clinical research coordinators have been mainly engaged in operational roles in industry-initiated clinical trials for drug approval (registration trials), broadening their contribution to cover more types of clinical research may lead to quality improvement of clinical research. To ultimately establish a clinical research infrastructure that meets the needs of the new era of Clinical Trials Act, here we gathered basic information on how clinical research coordinators might make such contributions.MethodsWe conducted a survey using self-reporting questionnaires in clinical research-related personnel to examine present status and the perspectives toward broader contribution of clinical research coordinators. The study participants were attendee of group discussion of a clinical research-related meeting in Shikoku area of Japan held in August 2017.ResultsAmong 88 participants, 69 responded (response rate: 78.4%) and 68 respondents (98.6%) were engaged in support and management of clinical research. The main area of involvement was industry-initiated registration trials (48, 69.7%), and main roles of involvement were cooperators who plays roles under the guidance of investigators (41, 59.5%). When divided by occupation into clinical research coordinators (n = 41) and other clinical research-related personnel (n = 28), approximately half of the respondents in each group replied positively to wanting broader involvement of clinical research coordinators as a clinical research professional.ConclusionThe present study revealed that about half of the clinical research coordinators and other clinical research-related personnel view a broadening of involvement of clinical research coordinators in research activities positively. Accordingly, a structured practical program aimed at encouraging such involvement may help to expand and strengthen their contribution into the future. Whether greater involvement of clinical research coordinators in clinical research will help to ensure the reliability of investigator-initiated clinical research warrants further study.

Academic investigators’ interest in promoting specified clinical trials : Questionnaire survey before and after implementation of the Clinical Trial Act

“…The questionnaire asked about the investigators' characteristics such as gender, position, experience with clinical trials, ethics committee applications, interest in each study design, and desire for human and physical resources required for the smooth promotion of clinical research. Many research organizations with AROs without full functions have evolved to support industry-initiated clinical trials, but are presumably not well-equipped to promote academia-initiated clinical research by their investigators (10,11). Since this feature is considered to be common to research organizations without AROs with full functions, the desires and interests considered necessary to promote research in these organizations were determined for various occupations (physician, pharmacist, nurse, and nutritionist) and departments.…”

Participation in and withdrawal from cancer clinical trials: A survey of clinical research coordinators

“…Clinical research coordinators (CRCs), such as research nurses, are core research professionals who coordinate and manage clinical trials. 7 , 8 In South Korea, new CRCs receive 40 ​h of training, and experienced CRCs receive 24 ​h of advanced training. 7 CRCs perform tasks, such as screening study subjects, patient education and acquisition of informed consent, scheduling clinical visits and contacting study subjects, completing case report forms, observing adverse events, and liaising with researchers and sponsors.…”

Data Validation and Verification Using Blockchain in a Clinical Trial for Breast Cancer: Regulatory Sandbox

“…The fabricated clinical data were used in an advertising campaign for the drug, and patients were prescribed the drug based on incorrect information. Following misconduct in clinical trials, the Japanese government established and enforced the Clinical Trials Act in 2018 [ 8 ]. It obligates clinical researchers to monitor and assure quality, observe practice criteria, and manage conflicts of interest.…”